Stay updated on LY3561774 in Mixed Dyslipidemia: PROLONG-ANG3 Clinical Trial
Sign up to get notified when there's something new on the LY3561774 in Mixed Dyslipidemia: PROLONG-ANG3 Clinical Trial page.

Latest updates to the LY3561774 in Mixed Dyslipidemia: PROLONG-ANG3 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 was added to the page history, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe record history now shows a new revision tag v3.3.2 in place of the previous v3.2.0, which is a minor metadata update to the history section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe government-funding/operating-status banner at the top of the page was removed. No study data or history details were changed.SummaryDifference0.5%

- Check64 days agoChange DetectedThe new screenshot displays small header and spacing adjustments without changing the version history data or core page content.SummaryDifference0.1%

- Check93 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference10%

- Check100 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.2%

Stay in the know with updates to LY3561774 in Mixed Dyslipidemia: PROLONG-ANG3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3561774 in Mixed Dyslipidemia: PROLONG-ANG3 Clinical Trial page.